195 related articles for article (PubMed ID: 29674164)
1. Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.
Tu V; Abed Y; Fage C; Baz M; Boivin G
Antiviral Res; 2018 Jun; 154():110-115. PubMed ID: 29674164
[TBL] [Abstract][Full Text] [Related]
2.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
3. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
[TBL] [Abstract][Full Text] [Related]
4. The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness.
Tu V; Abed Y; Barbeau X; Carbonneau J; Fage C; Lagüe P; Boivin G
Antiviral Res; 2017 Jan; 137():6-13. PubMed ID: 27838351
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors.
Fage C; Abed Y; Checkmahomed L; Venable MC; Boivin G
Viruses; 2018 Dec; 11(1):. PubMed ID: 30583488
[TBL] [Abstract][Full Text] [Related]
6. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK
J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
[TBL] [Abstract][Full Text] [Related]
7. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.
Abed Y; Pizzorno A; Bouhy X; Rhéaume C; Boivin G
J Virol; 2014 Feb; 88(3):1652-8. PubMed ID: 24257597
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
[TBL] [Abstract][Full Text] [Related]
9. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
Abed Y; Bouhy X; L'Huillier AG; Rhéaume C; Pizzorno A; Retamal M; Fage C; Dubé K; Joly MH; Beaulieu E; Mallett C; Kaiser L; Boivin G
Antiviral Res; 2016 Aug; 132():6-12. PubMed ID: 27185624
[TBL] [Abstract][Full Text] [Related]
10. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
L'Huillier AG; Abed Y; Petty TJ; Cordey S; Thomas Y; Bouhy X; Schibler M; Simon A; Chalandon Y; van Delden C; Zdobnov E; Boquete-Suter P; Boivin G; Kaiser L
J Infect Dis; 2015 Dec; 212(11):1726-34. PubMed ID: 25985905
[TBL] [Abstract][Full Text] [Related]
11. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
[TBL] [Abstract][Full Text] [Related]
12. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
[TBL] [Abstract][Full Text] [Related]
13. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
[TBL] [Abstract][Full Text] [Related]
14. Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.
Farrukee R; Butler J; Reading PC; Hurt AC
Antiviral Res; 2019 Aug; 168():68-75. PubMed ID: 31132385
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
16. Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors.
Fage C; Tu V; Carbonneau J; Abed Y; Boivin G
Antivir Ther; 2017; 22(8):711-716. PubMed ID: 29082897
[TBL] [Abstract][Full Text] [Related]
17. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A
Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866
[TBL] [Abstract][Full Text] [Related]
18. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
Abed Y; Baz M; Boivin G
Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
[TBL] [Abstract][Full Text] [Related]
19. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
[TBL] [Abstract][Full Text] [Related]
20. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.
Little K; Leang SK; Butler J; Baas C; Harrower B; Mosse J; Barr IG; Hurt AC
Euro Surveill; 2015; 20(45):. PubMed ID: 26608955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
